Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huperzine A to reduce postoperative delirium after microvascular decompression
ChiCTR2000033906Phase 4Recruiting
- Sponsor
- Xinhua Hospital
- Start
- Jun 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative delirium (POD) comparing Huperzine A injection with Normal saline placebo (2 arms). Primary endpoint: Delirium rating scale. Started Jun 2020; status: recruiting.
02
Drugs
Huperzine A
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2000033906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033906.